Charity news

Our founder, and also Chairman since 1988, Eddie O’Gorman has decided to step down as Chairman as of 12 January 2022. We’re all so driven to continue the O’Gorman family legacy and help achieve a future where every child survives cancer.

Scientists at UCL have found that a mutation commonly seen in osteosarcomas, the most common type of bone cancer, could render tumours susceptible to a licensed group of cancer treatments known as PARP inhibitors.

Listen to Bella-Rose’s update. She was diagnosed with cancer when she was just three years old and  spent many Christmases in hospital. This year she’s looking forward to spending Christmas at home with her family.

Please give other children the chance to spend Christmas at home with their family.

Alice was diagnosed with high-risk neuroblastoma a week before her second birthday in 2019. Neuroblastoma is a type of cancer which only has a 50% survival rate. We believe that no parent should be told that their child only has a 50% chance of survival.

That is why research is still urgently needed.

We have joined with 50 other cancer charities to form One Cancer Voice. This weekend One Cancer Voice  has made the urgent call for the Comprehensive Spending Review to deliver Government commitments to improve cancer survival and care.

We’re funding new research, led by Professor Tariq Enver, a world leader in the field of leukaemia.

Current treatments for children with acute lymphoblastic leukaemia (ALL) are highly toxic meaning children may  suffer long term side effects.

This project aims to develop more targeted and less toxic therapies which will reduce the toxic effects on the rest of the body.

Children and young people living with cancer from across the West Midlands, Oxfordshire and parts of Southern England will now benefit from improved genetic testing, thanks to a seven-figure donation to Birmingham Children’s Hospital Charity from Children with Cancer UK, in partnership with Kwik-Fit.

Cancer Research UK and Children with Cancer UK are joining forces to fund five teams of world-leading scientists. Each team has been awarded up to £1 million to delve into the biology of children’s and young people’s cancers.